International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 998-1004 , 15 March 2010

Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial

Presented at the 48th American Society for Therapeutic Radiology and Oncology Annual Meeting, November 5–9, 2006, Philadelphia, PA.

  • Janet K. Horton, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Corresponding Author InformationReprint requests to: Janet K. Horton, M.D., Department of Radiation Oncology, Duke University Medical Center, DUMC 3085, Durham, NC 27710. Tel: (919) 668-5213; Fax: (919) 668-7345
  • ,
  • Jan Halle, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • ,
  • Madlyn Ferraro, R.N.

      Affiliations

    • Lineberger Comprehensive Cancer Center, Chapel Hill, NC
  • ,
  • Lisa Carey, M.D.

      Affiliations

    • Department of Internal Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • ,
  • Dominic T. Moore, M.P.H.

      Affiliations

    • Lineberger Comprehensive Cancer Center, Chapel Hill, NC
  • ,
  • David Ollila, M.D.

      Affiliations

    • Department of Surgery, Division of Surgical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • ,
  • Carolyn I. Sartor, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC

Received 26 November 2008 ,Revised 5 March 2009 ,Accepted 12 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Support and third-party writing assistance provided by Genentech USA, Inc., South San Francisco, CA.

 Conflict of interest: none.

PII: S0360-3016(09)00464-7

doi: 10.1016/j.ijrobp.2009.03.027

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 998-1004 , 15 March 2010